| Exposed uninfected n = 125 | Infected n = 417 | Unadjusted p-value3 | Adjusted Odds Ratio (95% CI)3 |
---|---|---|---|---|
Female gender (%) Median age, days (IQR) | 57 (46) 48 (38-51) | 239 (57) 45 (38-56) | 0.18 0.071 | Â |
Anthropometry at screening | ||||
Median weight, kg (IQR) | 4.8 (4.3-5.2) | 4.4 (3.9-4.9) | < 0.0012 | 0.51 (0.38-0.68) |
Weight < 3 rd centile (%) | 8 (6.4) | 79 (18.9) | < 0.001 | 3.2 (1.4-6.8) |
Weight < 15 th centile (%) | 23 (18.4) | 166 (39.8) | < 0.001 | 2.8 (1.7-4.6) |
Weight < 50 th centile (%) | 79 (63.2) | 303 (72.7) | 0.04 | 1.5 (0.98-2.3) |
Median length, cm | 55 (53-56) | 54 (52-56) | 0.782 | 0.97 (0.91-1.04) |
Median HC, cm | 39 (38.4-40) | 39 (38-40) | 0.202 | 0.95 (0.88-1.03) |
Physical exam findings at screening | ||||
Any LAD # (%) | 6 (5) | 132 (32) | < 0.001 | 8.8 (3.8-20.9) |
Candidal rash (%) | 8 (6) | 46 (11) | 0.17 | 1.6 (0.8-3.6) |
Atopic dermatitis (%) | 13 (10) | 83 (20) | 0.01 | 2.0 (1.1-3.7) |
Diaper dermatitis | 23 (18) | 149 (36) | < 0.001 | 2.4 (1.5-4.0) |
Oral thrush (%) | 13 (10) | 163 (39) | < 0.001 | 5.6 (3.0-10.2) |
Hepatomegaly (%) | 1 (1) | 70 (17) | < 0.001 | 23.5 (3.2-170.8) |
Splenomegaly (%) | 0 (0) | 30 (7) | < 0.001 | * |
Clinical event prior to or at screening | ||||
Gastroenteritis (%) | 8 (6) | 44 (11) | 0.17 | 1.7 (0.8-3.7) |
Otitis media (%) | 4 (3) | 6 (1) | 0.20 | 0.4 (0.1-1.5) |
Sepsis (%) | 3 (2) | 12 (3) | 1.00 | 1.0 (0.3-3.7) |
URTI (%) | 24 (19) | 81 (19) | 1.00 | 1.0 (0.6-1.7) |
Reflux (%) | 0 (0) | 15 (4) | 0.03 | * |
Pneumonia (%) | 7 (6) | 29 (7) | 0.67 | 1.2 (0.5-2.8) |
Laboratory findings | ||||
Anemia (%) | 0 (0) | 22 (5) | 0.004 | * |
Neutropenia (%) | 0 (0) | 15 (4) | 0.03 | * |